Document:

exv10w2

Exhibit 10.2

SUMMARY OF FISCAL YEAR 2011 EXECUTIVE OFFICER

ANNUAL CASH INCENTIVE COMPENSATION PLAN

     For the twelve month period ending June 30, 2011, each executive officer of Cardiovascular
Systems, Inc. is eligible to receive cash incentive compensation as follows:

     Revenue and Adjusted EBITDA Financial Goals

     Receipt of cash incentive compensation for fiscal 2011 is based on the Company’s achievement
of revenue and adjusted EBITDA financial goals. Target bonus amounts are split evenly between
these two goals. None of the executive officers is subject to individual goals under the plan.
Target bonus levels as a percentage of base salary are 75% for the President and Chief Executive
Officer and 50% for the other executive officers. Depending upon the Company’s performance against
the goals, participants are eligible to earn 50% to 150% of their target bonus amount for adjusted
EBITDA and 50% to 150% of their target bonus amount for revenue; however, in the event of
extraordinary revenue performance above the goals set by the Board, the participants could receive
incentive payments greater than 150% of their targets for the revenue goal based upon a formula
established by the Board, with no maximum payout set under the plan. The plan criteria are the same
for all of the executive officers.

     Management by Objective Targets

     The plan also provides “management by objective” (MBO) targets related to certain
predetermined FDA and product achievement milestones for the first six months and full year periods
of fiscal 2011. Achievement of the MBO targets could result in additional cash bonuses to executive
officers of 3.75% of their annual base salaries for each of the target periods.

     Other Incentives

     In addition to incentives under the plan, the Company’s Vice President of Sales and Vice
President of Business Development are eligible to receive monthly sales commissions. The Board also
has authority to grant additional discretionary cash bonuses of up to 10% of annual base salary for
any executive officer.exv10w3

Exhibit 10.3

SETTLEMENT AGREEMENT

     THIS SETTLEMENT AGREEMENT (“Agreement”) is made and entered into among ev3 Inc., ev3
Endovascular, Inc., (collectively, “ev3”), FoxHollow Technologies, Inc., (“FoxHollow”), Tyco
Healthcare Group LP d/b/a Covidien (“Covidien”), Cardiovascular Systems, Inc. (“CSI”), Aaron Lew
(“Lew”), Paul Tyska (“Tyska”), Sean Collins (“Collins”), David Gardner (“Gardner”), Michael Micheli
(“Micheli”), Kevin Moore (“Moore”), Steve Pringle (“Pringle”), Jason Proffitt (“Proffitt”), Thadd
Taylor (“Taylor”), and Rene Treanor-Sarria (“Treanor-Sarria”). The above identified persons are
referred to collectively as “Parties” and individually as “Party.”

     RECITALS:

     1. ev3 and FoxHollow commenced a lawsuit in Ramsey County District Court, State of Minnesota
entitled ev3 Inc., et al. v. Cardiovascular Systems, Inc., et al., Court File No. 62
CV-07-5977 (“Lawsuit”). CSI asserted counterclaims in the Lawsuit. Collins, Gardner, Micheli,
Moore, Pringle, Proffitt, Taylor and Treanor-Sarria were subsequently dismissed from the Lawsuit in
their capacity as individual defendants.

     2. The Parties wish to settle and fully and finally resolve and terminate all disputes and
claims between them under the terms set forth in this Agreement.

     AGREEMENT:

     NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are
hereby universally acknowledged, the Parties agree as follows:

     1. Payment. CSI shall deliver the sum of One Million and No/100 Dollars
($1,000,000.00) to ev3 as follows:

     (a) Seven Hundred Fifty Thousand and No/100 Dollars ($750,000.00) shall be delivered to
ev3 by certified funds or wire transfer on or before October 29, 2010; and

     (b) Two Hundred Fifty Thousand and No/100 Dollars ($250,000.00) shall be delivered by
CSI as a Promissory Note in the form of the document attached hereto as Exhibit A
(“Promissory Note”), which shall be executed and delivered to ev3 on or before October 29,
2010.

     2. Mutual Releases. The Parties agree to a full, final and mutual release of all
claims and disputes as provided below; however, the releases shall not extend to: i) obligations
created by this Agreement; ii) the Promissory Note; or iii) any contractual obligation of a person
formerly employed by ev3 or FoxHollow (who subsequently became employed by CSI) relating to ev3 or
FoxHollow’s proprietary, confidential or trade secret information, except as to actions, inactions
or matters that have occurred or arisen as of October 29, 2010, all of such rights and obligations
are specifically reserved.

1

 

With these exceptions, the Parties agree to the following releases:

     (a) ev3, FoxHollow, and Covidien’s Release of CSI. ev3, FoxHollow, and
Covidien, on behalf of themselves and their predecessors, successors, parent entities,
subsidiaries, affiliates, officers, directors, employees, agents, attorneys, shareholders,
insurers and assigns (collectively, “ev3 Releasing Parties”), hereby forever, fully and
unconditionally release and discharge CSI and its predecessors, successors, parent entities,
subsidiaries, affiliates, and all of their present and former officers, directors,
employees, agents, attorneys, shareholders, insurers and assigns (collectively, “CSI
Released Parties”), from all obligations, offsets, actions, suits, debts, sums of money,
contracts, covenants, agreements, promises, legal rights, claims, counterclaims, causes of
action, demands, damages, costs, compensation, liabilities, losses and expenses of any
nature or of any kind, whether known or unknown, asserted or unasserted, liquidated or
unliquidated, absolute or contingent, accrued or nonaccrued, which any of the ev3 Releasing
Parties ever had, now have, or claim to have, whether grounded in law or equity, in contract
or in tort, by statute or otherwise against any or all of the CSI Released Parties by reason
of any action, inaction or matter whatsoever occurring or arising on or prior to October 29,
2010.

     It is the intention of the Parties that this release shall operate as a full and final
settlement of any of the CSI Released Parties’ past, present, direct, indirect, and
derivative liabilities to any and all of the ev3 Releasing Parties relating to or arising
out of events and occurrences taking place on or prior to October 29, 2010.

     (b) ev3, FoxHollow, and Covidien’s Release of Lew, Tyska, Collins, Gardner,
Micheli, Moore, Pringle, Proffitt, Taylor, and Treanor-Sarria. ev3 Releasing Parties
hereby forever, fully and unconditionally release and discharge Lew, Tyska, Collins,
Gardner, Micheli, Moore, Pringle, Proffitt, Taylor, and Treanor-Sarria and their respective
representatives, heirs, agents, assigns, attorneys, and spouses, if any, (collectively,
“Released individuals”), from all obligations, offsets, actions, suits, debts, sums of
money, contracts, covenants, agreements, promises, legal rights, claims, counterclaims,
causes of action, demands, damages, costs, compensation, liabilities, losses and expenses of
any nature or of any kind, whether known or unknown, asserted or unasserted, liquidated or
unliquidated, absolute or contingent, accrued or nonaccrued, which any of the ev3 Releasing
Parties ever had, now have, or claim to have, whether grounded in law or equity, in contract
or in tort, by statute or otherwise against any or all of the Released Individuals by reason
of any action, inaction or matter whatsoever occurring or arising on or prior to October 29,
2010.

     It is the intention of the Parties that this release shall operate as a full and final
settlement of any of the Released Individuals’ past, present, direct, indirect, and
derivative liabilities to any and all of the ev3 Releasing Parties relating to or arising
out of events and occurrences taking place on or prior to October 29, 2010.

     The Parties understand that ev3 Releasing Parties are not releasing the Released
Individuals from any future obligations to maintain the confidentiality of ev3 or

2

 

FoxHollow’s confidential, proprietary or trade secret information as may be set forth
in an agreement with ev3 and/or FoxHollow.

     (c) CST’s Release of ev3, FoxHollow and Covidien. CST, on behalf of itself and
its predecessors, successors, parent entities, subsidiaries, affiliates, officers,
directors, employees, agents, attorneys, shareholders, insurers and assigns (collectively,
“CSI Releasing Parties”), hereby forever, fully and unconditionally release and discharge
ev3, FoxHollow and Covidien and their predecessors, successors, parent entities,
subsidiaries, affiliates, and all of their present and former officers, directors,
employees, agents, attorneys, shareholders, insurers and assigns (collectively, “ev3
Released Parties”), from all obligations, offsets, actions, suits, debts, sums of money,
contracts, covenants, agreements, promises, legal rights, claims, counterclaims, causes of
action, demands, damages, costs, compensation, liabilities, losses and expenses of any
nature or of any kind, whether known or unknown, asserted or unasserted, liquidated or
unliquidated, absolute or contingent, accrued or nonaccrued, which any of the CSI Releasing
Parties ever had, now have, or claim to have, whether grounded in law or equity, in contract
or in tort, by statute or otherwise against any or all of the ev3 Released Parties by reason
of any action, inaction or matter whatsoever occurring or arising on or prior to October 29,
2010.

     It is the intention of the Parties that this release shall operate as a full and final
settlement of any of the ev3 Released Parties’ past, present, direct, indirect, and
derivative liabilities to any and all of the CSI Releasing Parties relating to or arising
out of events and occurrences taking place on or prior to October 29, 2010.

     (d) Lew, Tyska, Collins, Gardner, Micheli, Moore, Pringle, Proffitt, Taylor, and
Treanor-Sarria’s Release of ev3, FoxHollow and Covidien. Lew, Tyska, Collins, Gardner,
Micheli, Moore, Pringle, Proffitt, Taylor, and Treanor-Sarria and their respective
representatives, heirs, agents, assigns, attorneys, and spouses, if any, (collectively,
“Individual Releasing Parties”), hereby forever, fully and unconditionally release and
discharge ev3 Released Parties, from all obligations, offsets, actions, suits, debts, sums
of money, contracts, covenants, agreements, promises, legal rights, claims, counterclaims,
causes of action, demands, damages, costs, compensation, liabilities, losses and expenses of
any nature or of any kind, whether known or unknown, asserted or unasserted, liquidated or
unliquidated, absolute or contingent, accrued or nonaccrued, which any of the Individual
Releasing Parties ever had, now have, or claim to have, whether grounded in law or equity,
in contract or in tort, by statute or otherwise against any or all of the ev3 Released
Parties by reason of any action, inaction or matter whatsoever occurring or arising on or
prior to October 29, 2010.

     It is the intention of the Parties that this release shall operate as a full and final
settlement of any of the ev3 Released Parties’ past, present, direct, indirect, and
derivative liabilities to any and all of the Individual Releasing Parties relating to or
arising out of events and occurrences taking place on or prior to October 29, 2010.

3

 

     The Parties understand that the Individual Releasing Parties are not releasing the ev3
Released Parties from any future obligation to arbitrate claims with them as may be set
forth in an agreement with ev3 and/or FoxHollow.

     3. No Admission of Liability. It is expressly understood and agreed that this
Agreement constitutes a compromise and settlement of disputed claims and that this Agreement is not
intended, nor shall it be construed by anyone, to be an admission of liability by or on behalf of
any Party hereto, by whom all such liability is expressly denied, the Parties intending merely to
avoid the cost and inconvenience of continuing with the Lawsuit.

     4. Attorneys’ Fees And Costs. It is agreed that each Party will bear its, his or her
own costs and expenses, including but not limited to attorneys’ fees, incurred with respect to the
Lawsuit, the drafting of this Agreement and the Promissory Note, and all other matters addressed in
or related to this Agreement, except that CSI shall be obligated to pay the holder of the
Promissory Note all reasonable costs and fees (including but not limited to reasonable attorneys’
fees), the holder incurs if the holder prevails in any proceeding to enforce or exercise its rights
to payment under the Promissory Note as set forth in the Promissory Note.

     5. Stipulation of Dismissal. Two (2) business days after the latter of the execution
of this Agreement and CSI’s satisfaction of its obligations under Paragraph 1 of this Agreement,
counsel for the Parties shall execute and file with the Ramsey County District Court a stipulation
of dismissal of the Lawsuit with prejudice and on the merits, and without an award of attorneys’
fees, costs or disbursements to any party, which shall include a stipulation to the dismissal and
vacation of the Court’s Order, dated January 10, 2008, in the form attached hereto as Exhibit B.

     6. Stipulated Protective Order. The Stipulated Protective Order, dated February 25,
2008, remains in full force and effect. The Parties agree that any subsequent dispute concerning
the Protective Order shall be decided by Rick Solum as a binding arbitrator.

     7. Governing Law; Venue. This Agreement shall be construed and interpreted under the
laws of the State of Minnesota without regard to its conflict-of-law principles.

     8. Severability. If any provision of this Agreement is held to be unlawful or
unenforceable in any respect by a court of competent jurisdiction, such provision shall be severed
and shall not affect the validity or enforceability of the remaining provisions. Further, if any
provision of this Agreement is held to be overbroad, such provision shall be deemed amended to
narrow the application to the extent necessary to render the provision enforceable according to
applicable law.

     9. Execution and Delivery. This Agreement may be executed in counterparts, which
taken together shall constitute one agreement binding on all parties. Facsimile and electronically
transmitted signatures shall be valid and binding to the same extent as signatures delivered in
original. In making proof of this Agreement, it will be necessary to produce only one copy signed
(or reproduced from an electronically delivered signature) by the Party to be charged.

     10. Benefit and Assignment. This Agreement shall be binding upon and inure to the
benefit of the Parties and their successors and permitted assigns.

4

 

     11. Consultation with Advisors; Knowing Agreement. Each Party represents that he,
she, or it has had the opportunity to consult with legal, financial, and other professional
advisors as he, she, or it deems appropriate in connection with his, her, or its consideration,
execution and delivery of this Agreement. Each Party represents that he, she, or it has read this
Agreement carefully and understands all of its terms.

     12. Entire Agreement. This Agreement and the documents attached hereto set forth the
entire agreement and understanding of the Parties regarding the ettlement of the claims described
in this Agreement, and this Agreement supersedes all prior representations, statements, proposals,
negotiations, discussions, understandings and agreements regarding such settlement, including but
not limited to the Binding Mediated Settlement Agreement entered into on October 4, 2010. This
Agreement may not be modified or amended except in a writing signed by all of the Parties hereto
that expressly references this Agreement.

     13. Construction. The headings herein are for convenience only, do not constitute a
part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof.
The Parties agree that each of them and their respective legal counsel has reviewed and had an
opportunity to revise this Agreement and, therefore, the normal rule of construction to the effect
that any ambiguities are to be resolved against the drafting party shall not be employed in the
interpretation of this Agreement. Instead, the language used in this Agreement will be deemed to
be the language chosen by the Parties to express their mutual intent.

     IN WITNESS WHEREOF, the undersigned have executed this Agreement.

	 	 	 	 	 	 	 

	 
	ev3 Inc.:	 	Cardiovascular Systems, Inc.:
	 
	By: 	 /s/ Michael Cowhig	 	By: 	   /s/ James E. Flaherty
	 	Its: Vice President	 	 	Its: Chief Administrative Officer
	 
	ev3 Endovascular, Inc.:	 	 	 	 
	 
	By: 	 /s/ Michael Cowhig	 	 	/s/ Aaron Lew
	 	Its: Vice President	 	 	Aaron Lew (individually)
	 
	FoxHollow Technologies, Inc.:	 	 	 	 
	 
	By: 	 /s/ Michael Cowhig	 	 	/s/ Paul Tyska
	 	Its: Vice President	 	 	Paul Tyska (individually)

5

 

	 	 	 	 	 	 	 

	 
	Tyco Healthcare Group LP d/b/a Covidien:	 	 	 	 
	 
	By: 	 /s/ Michael Cowhig	 	 	/s/ Sean Collins
	 	Its: Vice President	 	 	Sean Collins (individually)
	 
	 	 	 	 	 	/s/ David Gardner
	 	 	 	 	 	David Gardner (individually)
	 
	 	 	 	 	 	/s/ Michael Micheli
	 	 	 	 	 	Michael Micheli (individually)
	 
	 	 	 	 	 	/s/ Kevin Moore
	 	 	 	 	 	Kevin Moore (individually)
	 
	 	 	 	 	 	/s/ Jason Proffitt
	 	 	 	 	 	Jason Profitt (individually)
	 
	 	 	 	 	 	/s/ Steve Pringle
	 	 	 	 	 	Steve Pringle (individually)
	 
	 	 	 	 	 	/s/ Thadd Taylor
	 	 	 	 	 	Thadd Taylor (individually)
	 
	 	 	 	 	 	/s/ Renee Treanor-Sarria
	 	 	 	 	 	Renee Treanor-Sarria (individually)

6

 

PROMISSORY NOTE

			
	 
	 	October 29, 2010
	$250,000.00
	 	St. Paul, Minnesota

     FOR VALUE RECEIVED, Cardiovascular Systems, Inc. (“Debtor”) hereby promises to pay to the
order of ev3 Inc. or its endorsees, successors and assigns (“Holder”), the principal sum of Two
Hundred Fifty Thousand and No/100 Dollars ($250,000.00) in the manner provided in this Promissory
Note (“Note”). The unpaid principal amount of this Note shall bear simple interest from the date
first above written at the rate of three and one-half percent (3.5%) per annum, which principal and
interest is due and payable on or before January 1, 2014.

     This Note is not secured and shall only be subordinate to any other debt of the Debtor
existing as of the date first above written.

     All payments of principal and interest shall be paid by Debtor to Holder at 3033 Campus Drive,
Plymouth, MN 55441, or at such other address as Holder may designate in writing to Debtor from time
to time by certified or registered mail. Debtor may prepay, with no penalty or premium, the
principal and interest of this Note, in whole or in part and from time to time. All payments shall
first be applied to interest on the unpaid principal amount and the remainder to principal.

     Upon the occurrence of any of the following events of default (each, an “Event of Default”),
and the passage of 10 business days following written notice of default without cure, all of the
then outstanding principal balance plus accrued interest of this Note shall automatically become
immediately due and payable:

	 	(a)	 	Debtor enters into a written agreement for the sale of all or substantially all
of its assets;
	 
	 	(b)	 	Debtor fails to satisfy a judgment in an amount exceeding $250,000 entered by a
court of law within sixty (60) days after entry of the judgment except as such judgment
is being appealed with a stay of any ability of the judgment creditor to execute on the
judgment; or
	 
	 	(c)	 	Debtor applies for, consents to, or acquiesces in the appointment of a trustee,
receiver or other custodian for itself or any of its property, or makes a general
assignment composition, or similar device for the benefit of its creditors; or a
trustee, receiver or other custodian is otherwise appointed for Debtor or any of its
assets; or an attachment or receivership of assets or any bankruptcy, reorganization,
debt arrangement, or other case or proceeding under any bankruptcy or insolvency law,
or any dissolution or liquidation proceeding is commenced by or against Debtor; or
Debtor takes any corporate action to authorize any of the foregoing.

EXHIBIT A

 

 

     Debtor shall be obligated to pay Holder all reasonable costs and fees (including but not
limited to reasonable attorneys’ fees) Holder incurs if Holder prevails in any proceeding to
enforce or exercise its rights to payment under this Note.

     Debtor hereby waives presentment for payment, protest and notice of non-payment. Debtor
hereby waives any right to set off and/or recoupment against Holder in connection with any claim it
now or hereafter may have against Holder, and agrees it will not urge or assert any claim including
but not limited to a set-off and/or recoupment, it may have now or hereafter against Holder as a
defense against payment of this Note.

     Holder shall not be deemed to have waived any of its rights or remedies under this Note unless
such waiver is expressed in a writing signed by Holder. No delay or omission by Holder in
exercising, or failure by Holder on any one or more occasions to exercise, any of Holder’s rights
hereunder, at law or in equity, including without limitation, Holder’s right after the occurrence
of any Event of Default to declare the entire indebtedness evidenced hereby immediately due and
payable, shall be construed as a novation of this Note or shall operate as a waiver or prevent the
subsequent exercise of any or all such rights.

     Acceptance by Holder of any portion or all of any sum payable hereunder, whether before, on or
after the due date of such payment shall not be a waiver of Holder’s right either to require prompt
payment when due of all other sums payable hereunder or to exercise any of Holder’s rights, powers
and remedies hereunder. Debtor expressly waives the benefit of any statute or rule of law or of
equity now provided, or which may hereafter be provided, which would produce a result contrary to,
or in conflict with, the foregoing.

     The provisions of this Note can not be changed, amended, or discharged orally, and any oral
change, amendment or discharge of any term or provision of this Note shall be without authority and
of no force or effect. The provisions of this Note can be changed, amended, or discharged only by
an instrument in writing signed by Debtor and Holder.

     All of the provisions of this Note are binding on Debtor’s successors and assigns and shall
inure to the benefit of Holder and its successors, assigns and endorsees, with Holder having the
unfettered right to assigns its rights under this Note.

     THE UNDERSIGNED WAIVES TRIAL BY JURY IN ANY JUDICIAL PROCEEDING TO WHICH ANY PARTIES TO THIS
INSTRUMENT ARE INVOLVED, ARISING OUT OF, RELATED TO, OR CONNECTED WITH THIS INSTRUMENT OR THE
RELATIONSHIP ESTABLISHED HEREUNDER.

     This Note is governed in all respects by the internal laws of the State of Minnesota without
regard to the conflicts-of-law rules of any jurisdiction.

[The remainder of this page is intentionally left blank.]

2

 

IN WITNESS WHEREOF, the Debtor has caused this Promissory Note to be signed by its duly authorized
officer as of the date first above written.

	 	 	 	 	 

	CARDIOVASCULAR SYSTEMS, INC.

	 	 
	 
	 	 	 	 
	By:
	 	 	 	 
	 

	 	 

	 	 
	
	 	Its: 	 	 
	 

	 	 

	 	 

3

 

	 	 	 	 	 

	STATE OF MINNESOTA
	 	 	 	DISTRICT COURT
	 
	 	 	 	 
	COUNTY OF RAMSEY
	 	 	 	SECOND JUDICIAL DISTRICT
	 
	 	 	 	CASE TYPE:  OTHER CIVIL
	ev3 Inc., a Delaware corporation, ev3
	 	)	 	 
	Endovascular, Inc., a Delaware
	 	)	 	Court File No. 62-CV-07-5977
	corporation, and FoxHollow Technologies,
	 	)	 	Honorable Robert A. Awsumb
	Inc., a Delaware corporation,
	 	)	 	 
	 
	 	)	 	 
	Plaintiffs,
	 	)	 	 
	 
	 	)	 	 
	vs.
	 	)	 	STIPULATION AND ORDER OF

	 
	 	)	 	DISMISSAL WITH PREJUDICE

	Cardiovascular Systems, Inc., a Minnesota
	 	)	 	 
	corporation, Aaron Lew, an individual, and
	 	)	 	 
	Paul Tyska, an individual,
	 	)	 	 
	 
	 	)	 	 
	Defendants.
	 	)	 	 

     IT IS HEREBY STIPULATED AND AGREED, by and between the parties to the above-captioned action,
through their undersigned counsel, that the Court may enter an Order as follows:

     1. The above-entitled action is dismissed with prejudice, on the merits and in its entirety,
with each party bearing its own costs, disbursements and attorneys’ fees; and

     2. The Court’s January 10, 2008, Order is dismissed and vacated, and the January 10, 2008,
Order shall have no further force or effect.

	 	 	 	 	 
	 	OPPENHEIMER WOLFF & DONNELLY LLP

 	 
	Dated:                     , 2010 	By:  	 	 
	 	 	Jeffrey J. Bouslog (#174671) 	 
	 	 	Kathy S. Kimmel (#268823)

Dennis E. Hansen (#386734)

45 South Seventh Street

Plaza VII Building, Suite 3300

Minneapolis, MN 55402-1609

(612) 607-7000

ATTORNEYS FOR PLAINTIFFS 	 

EXHIBIT B 

 

	 	 	 	 	 

	 	 	 	 	 
	 	ANTHONY OSTLUND BAER & LOUWAGIE PA.

 	 
	Dated:                     , 2010 	By:  	 	 
	 	 	Joseph W. Anthony (2872) 	 
	 	 	Mary L. Knoblauch (159645)

Courtland C. Merrill (311984)

3600 Wells Fargo Center

90 South Seventh Street

Minneapolis, MN 55402

(612) 349-6969

ATTORNEYS FOR DEFENDANTS 	 
	 

ORDER

     Pursuant to the foregoing stipulation, IT IS HEREBY ORDERED THAT:

     1. The stipulation of the parties is hereby adopted by the Court and incorporated by
reference.

     2. The above-entitled action is dismissed with prejudice, on the merits and in its entirety,
with each party bearing its own costs, disbursements and attorneys’ fees.

     3. The Court’s Order entered in this action on January 10, 2008, is dismissed and vacated, and
the January 10, 2008, Order shall have no further force or effect.

	 	 	 	 	 
	 	BY THE COURT:

 	 
	Dated:                     , 2010
 	Robert A. Awsumb

Judge of District Court

 	 

2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00180-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00180-of-00352.parquet"}]]